<unk>  (marketed under brand names Doral, Dormalin) is a relatively long-acting benzodiazepine derivative drug developed by the Schering Corporation in the 1970s.<unk>  is indicated for the treatment of insomnia including sleep induction and sleep maintenance.<unk>  induces impairment of motor function and has relatively (and uniquely) selective hypnotic and anticonvulsant properties with considerably less overdose potential than other benzodiazepines (due to its novel receptor-subtype selectively).<unk>  is an effective hypnotic which induces and maintains sleep without disruption of the sleep architecture. It was patented in 1970 and came into medical use in 1985.
Quazepam
Halazepam
Oxazepam
Triazolam
Gidazepam
Nordazepam
Bromazepam
Cinolazepam